|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03681 SINOMAB BIO-B
Nominal 
1.100 +0.010 (+0.917%) | 2024/06 - Interim RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | (133,847) | (300,538) | (147,063) | (141,338) |
| Net Cash from / (used in) Investing Activities | -- | (96,921) | (81,358) | (137,702) | (179,218) |
| Net Cash from / (used in) Financing Activities | -- | 82,267 | 102,285 | 57,515 | (18,808) |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | (148,501) | (279,611) | (227,250) | (339,364) |
| Cash & Cash Equivalents at beginning of period | -- | 342,887 | 562,983 | 810,370 | 1,200,868 |
| Effect of Foreign Exchange Rate Changes | -- | 9,278 | 59,515 | (20,137) | (51,134) |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 203,664 | 342,887 | 562,983 | 810,370 |
| Remarks: | Real time quote last updated: 24/12/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -90,622,000 |
| %Change | -32.420% |
| EPS / (LPS) | RMB -0.080 |
| NBV Per Share (¥) | RMB 0.254 |